Search

Author/Creator Tymofyeyev, Yevgen

3. FTS3‐01‐04: FINAL EFFICACY, SAFETY AND BIOMARKER RESULTS OF THE PHASE 2B/3 RANDOMIZED, DOUBLE‐BLINDED, PLACEBO‐CONTROLLED EARLY TRIAL OF ATABECESTAT IN PRECLINICAL ALZHEIMER'S DISEASE. (1st July 2019)

Authors:
Henley, David; Sperling, Reisa A.; Aisen, Paul S.; Raman, Rema; Donohue, Michael C.; Ernstrom, Karin; Shi, Yingqi; Karcher, Keith; Raghavan, Nandini; Tymofyeyev, Yevgen; Brashear, Robert; Novak, Gerald P.; Thipphawong, John; Saad, Ziad; Kolb, Hartmuth C.; Romano, Gary
Journal:
Alzheimer's & dementia
Issue:
Volume 15:Supplement 7S(2019)Part 17
Page Start:
P873
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Type I Error Considerations in Master Protocols With Common Control in Oncology Trials: Report of an American Statistical Association Biopharmaceutical Section Open Forum Discussion. (3rd August 2022)

Authors:
Sridhara, Rajeshwari; Marchenko, Olga; Jiang, Qi; Pazdur, Richard; Posch, Martin; Redman, Mary; Tymofyeyev, Yevgen; Li, Xiaoyun (Nicole); Theoret, Marc; Shen, Yuan Li; Gwise, Thomas; Hess, Lorenzo; Coory, Michael; Raven, Andrew; Kotani, Naoto; Roes, Kit; Josephson, Filip; Berry, Scott; Simon, Ric...
Journal:
Statistics in biopharmaceutical research
Issue:
Volume 14:Number 3(2022)
Page Start:
349
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗